Metsy GP-1 Tablets
Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP
Metsy GP-1
Description
Metsy GP-1 Tablets are an oral anti-diabetic medication that combines Metformin Hydrochloride Prolonged Release and Glimepiride to help effectively control blood sugar levels in patients with Type 2 Diabetes Mellitus. This combination therapy works through complementary mechanisms to improve glycemic control and reduce the risk of diabetes-related complications.
Metformin helps lower blood glucose levels by reducing glucose production in the liver and improving the body’s sensitivity to insulin. The prolonged-release formulation provides sustained blood sugar control throughout the day. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, helping the body utilize glucose more effectively.
Metsy GP-1 Tablets are commonly prescribed along with proper diet and exercise to manage blood sugar levels, improve metabolic control, and reduce symptoms associated with diabetes such as fatigue, excessive thirst, and frequent urination.
Key Benefits
-
Helps effectively control blood sugar levels
-
Combines dual mechanisms for improved glycemic control
-
Improves insulin sensitivity and glucose utilization
-
Reduces excessive glucose production by the liver
-
Helps prevent diabetes-related complications
-
Supports long-lasting blood sugar management
Composition
Each tablet contains:
-
Metformin Hydrochloride (Prolonged Release) I.P. – 500 mg
-
Glimepiride I.P. – 1 mg
Dosage Form
Tablets
Indications
-
Type 2 Diabetes Mellitus
-
Poor glycemic control with diet and exercise alone
-
Blood sugar management in diabetic patients
-
Prevention of diabetes-related complications
Dosage & Administration
Take the tablet as directed by a healthcare professional, usually once daily with meals to reduce gastrointestinal discomfort. The dosage may vary depending on the patient’s condition and blood sugar levels.
Storage Instructions
-
Store in a cool and dry place
-
Protect from direct sunlight and moisture
-
Keep out of reach of children
Safety Information
-
Use only under medical supervision
-
Monitor blood glucose levels regularly
-
Inform your doctor if you have kidney, liver, or heart conditions
-
Avoid alcohol consumption as it may increase the risk of side effects
Why Choose Metsy GP-1?
Metsy GP-1 Tablets combine the glucose-lowering benefits of Metformin Prolonged Release with the insulin-stimulating action of Glimepiride, providing effective and sustained blood sugar control for patients with Type 2 Diabetes while supporting better metabolic health.





